Company / Free Cash Flow per Share
Pfizer Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$1.59
FY2025
5-year range
$1.59 / $5.23
FY2021-FY2025
Trend
-7.3%
vs FY2024
Sector context
#38 of 192
Health Care
What the data says
Pfizer's free cash flow per share of $1.59 is higher than 80% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $1.59 in FY2025 to $5.23 in FY2023.
Based on SEC 10-K filings.
1.59 in FY2025 with a 5-year CAGR of -4.8%. Top quartile in the Health Care sector.
Declined from $5.23 to $1.59 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -9.7%
- 5-Year CAGR
- -4.8%
- 10-Year CAGR
- -
Sector benchmark
+108.0% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 7.3% year-over-year.
- Ranks #38 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.59 | -7.3% |
| FY2024 | $1.72 | -67.2% |
| FY2023 | $5.23 | +142.0% |
| FY2022 | $2.16 | +16.4% |
| FY2021 | $1.86 | -8.8% |
| FY2020 | $2.04 | +17.1% |
| FY2019 | $1.74 | -25.4% |
| FY2018 | $2.33 | +9.8% |
| FY2017 | $2.12 | -14.1% |
| FY2016 | $2.47 | +28.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026